Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 239,501,546 papers from all fields of science
Search
Sign In
Create Free Account
dalcetrapib
Known as:
S-(2-((1-(2-ethylbutyl)cyclohexane)carbonylamino)phenyl) 2-methylpropanethioate
A cholesteryl ester transfer protein (CETP) inhibitor that can produce an increase in serum HDL-cholesterol levels and a decrease in serum LDL…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Anticholesteremic Agents
Sulfhydryl Compounds
Narrower (2)
JTT 705
R1658
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
High-Density Lipoprotein-Targeted Therapy for Coronary Heart Disease:
G. Chi
,
Zahra Karimi
,
+4 authors
A. Kalayci
2018
Corpus ID: 212478378
The potential beneficial role of high-density lipoprotein (HDL) in preventing coronary heart disease (CHD) was first reported in…
Expand
2018
2018
[Treatment of dyslipidemia - is here still place for CETP-inhibitors?]
J. Murín
,
M. Pernický
,
S. Kinova
Vnitrni lekarstvi
2018
Corpus ID: 46409205
In the treatment of dyslipidemias about 5-6 years back a new class of drugs emerged, CETP (cholesteryl ester transfer protein…
Expand
2017
2017
CETP inhibitors stumble on
Asher Mullard
Nature reviews. Drug discovery
2017
Corpus ID: 29280496
Merck is one of just a few companies that has persevered. In August, the company reported detailed results from a 30,500-patient…
Expand
2016
2016
Les effets du dalcetrapib, un inhibiteur de la protéine de transfert des esters de cholestérol (CETP), sur la structure et la fonction des lipoprotéines de haute densité (HDL) dans l’étude dal…
Marie P. Beaudet
2016
Corpus ID: 90225627
2013
2013
Synthesis of Dalcetrapib
Jun-Da Cen
2013
Corpus ID: 88316593
1-(2-Ethylbutyl)cyclohexanecarbonyl chloride(8) was prepared from esterification of cyclohexanecarboxylic acid(4),followed by…
Expand
Review
2011
Review
2011
[Novel therapy for atherosclerosis and inflammatory vascular disease].
Akihiro Inazu
Nihon rinsho. Japanese journal of clinical…
2011
Corpus ID: 21585333
How to manage residual atherosclerosis risk after the statin therapy is a major concern in cardiovascular medicine. In addition…
Expand
2009
2009
Abstract 1271: The Effects of Dalcetrapib on Macrophage Reverse Cholesterol Transport in a Rodent Model
E. Niesor
,
H. Okamoto
,
+5 authors
M. Kakutani
2009
Corpus ID: 58483977
2009
2009
Abstract 1092: Dalcetrapib Binds to and Changes the Conformation of CETP in a Unique Manner (Differing to That Observed With Torcetrapib)
C. Maugeais
,
C. Magg
,
+8 authors
E. Niesor
2009
Corpus ID: 67960395
2008
2008
Gateways to clinical trials. July-August 2008.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2008
Corpus ID: 23111308
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept…
Expand
1976
1976
News in brief
Anonymous
Nature reviews. Drug discovery
1976
Corpus ID: 2569086
[...]there's no guidance." On 1 May, the US Food and Drug Administration (FDA) granted an 'emergency-use authorization' for…
Expand